One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1016/j.jinf.2022.04.010
Copy DOI Journal: The Journal of infection |  Publication Date: Apr 7, 2022 |
 Citations: 16 |  License type: NO-CC CODE |
Affiliation: Research Unit on Infectious and Emerging Tropical Diseases, Centre Hospitalier Universitaire de Toulouse, Inserm, Université Toulouse III - Paul Sabatier, French National Centre for Scientific Research, Pierre Louis Institute of Epidemiology and Public Health, Sorbonne Université, Hôpital Necker-Enfants Malades, Assistance Publique – Hôpitaux de Paris, Hôpital Bichat-Claude-Bernard, Claude Bernard University Lyon 1, Hôpital Saint-AntoineOutcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S COCOPREV study)
Sign-in/Register to access full text options 
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
